CClinicalTrials.gg
CompletedNCT04161846Updated Jun 9, 2021

Virtual World Training for Community Health Workers (CHW)

An interventional study of Virtual Training and In Person Training in Diabetes Mellitus Risk, sponsored by University of Delaware. Completed at 1 site in United States. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-09.

Sponsored by University of Delaware · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Standard, effective, and scalable training models are needed to help equip community health workers in their community-based diabetes prevention awareness efforts. This study will tailor/adapt, implement, and evaluate an innovative internet-based virtual world model to remotely deliver a diabetes prevention awareness training program to community health workers.

Read the detailed description

Standard, effective, and scalable training models are needed to help equip community health workers in their community-based diabetes prevention awareness efforts. This study will tailor/adapt, implement, and evaluate an innovative internet-based virtual world model to remotely deliver a diabetes prevention awareness training program to community health workers. A sequential mixed-methods design is used to address these specific aims: 1. Use community-based participatory research methods to guide the overall study and inform tailoring and adaptation of our virtual world model to deliver the CHW training program; 2. Conduct a randomized pilot study to compare change in primary outcomes (0, 12 weeks) after the in-person versus virtual world delivery of the program; and 3. Conduct summative focus groups to gather information to refine the program and study methodology.

02

Conditions studied

  • Diabetes Mellitus Risk
03

In context

Lead sponsor

University of Delaware is the lead sponsor of 125 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • community health worker
  • 18-65 years old
  • Female
  • Of African American/Black/African ancestry
  • not getting 150 minutes of physical activity weekly and/or overweight
  • residing in Chicago/driving distance to Chicago study site
  • regular access to internet and computer

Exclusion criteria

Exclusion Criteria:

  • does not meet inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Virtual World Program

    Participants take part in a group training delivered using a virtual world approach.

    Behavioral: Virtual Training

  • Active comparator
    In Person Program

    Participants take part in a group training delivered using an in person approach.

    Behavioral: In Person Training

Interventions

  • BehavioralVirtual Training

    The intervention involves a CHW training focused on raising awareness of diabetes prevention in the community. It is delivered remotely over 10 weeks using an internet based approach.

  • BehavioralIn Person Training

    The intervention involves a CHW training focused on raising awareness of diabetes prevention in the community. It is delivered in person over 10 weeks.

06

What researchers measure

Primary outcomes

  1. Change in content knowledge will be measured using the program Knowledge Questionnaire

    Program content knowledge will be assessed using an adapted version of the original training program knowledge questionnaire. Scores represent the number of content questions answered correctly. Higher scores represent greater program knowledge.

    Time frame: Following program completion (10-12 weeks)

  2. Post Training Presentation Delivery Skills

    Each CHW will be asked to prepare and deliver a brief presentation, including 3 standardized topic areas.

    Time frame: Following program completion (10-12 weeks)

Secondary outcomes

  1. Change in Lifestyle Habits

    Eating habits will be assessed using the Visually-Enhanced Food Behavior Checklist.

    Time frame: Following program completion (10-12 weeks)

  2. Change in Physical Activity

    Physical activity will be assessed with International Physical Activity Questionnaire (IPAQ).

    Time frame: Following program completion (10-12 weeks)

Other outcomes

  1. Change in self-efficacy and Stage of Change. A Self-Efficacy Index will be used and Stage of Change individual questions will be used for healthy eating and physical activity.

    A multi-item index of self-efficacy will be used to examine confidence in making lifestyle changes and in delivering the content. Higher scores represent greater confidence. Stage of change questions will assess CHW motivation (i.e., pre-contemplation, contemplation, preparation) or achievement of eating habit and physical activity behaviors (i.e., action/maintenance stages).

    Time frame: Following program completion (10-12 weeks)

  2. Adherence

    Attendance will be measured by a count of the number of training sessions attended.

    Time frame: During training sessions (up to 10 weeks).

07

Study locations

1 site
  • UIC College of Nursing
    Chicago, Illinois 60612, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04161846
Lead sponsor
University of Delaware
Collaborators
University of Illinois at Chicago
Responsible party
Laurie Ruggiero, Ph.D. (Professor, University of Delaware) — Principal investigator
First posted
Nov 13, 2019
Start date
Aug 8, 2019
Primary completion
Apr 25, 2021
Completion
Apr 25, 2021
Last update
Jun 9, 2021

Study contacts

Laurie Ruggiero, Ph.D
principal investigator · University of Delaware

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion